Shengyong Luo

537 total citations
20 papers, 389 citations indexed

About

Shengyong Luo is a scholar working on Neurology, Molecular Biology and Immunology. According to data from OpenAlex, Shengyong Luo has authored 20 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 6 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Shengyong Luo's work include Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Neurological Disease Mechanisms and Treatments (5 papers) and Immune cells in cancer (3 papers). Shengyong Luo is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Neurological Disease Mechanisms and Treatments (5 papers) and Immune cells in cancer (3 papers). Shengyong Luo collaborates with scholars based in China, United States and Saint Kitts and Nevis. Shengyong Luo's co-authors include Zhiwu Chen, Qinglin Li, Rui Li, Zheng Ma, Xiangrong Dai, Xiaoyi Li, Huan Wu, Yide Qin, Shuo Chen and Hui Cheng and has published in prestigious journals such as PLoS ONE, The Science of The Total Environment and British Journal of Pharmacology.

In The Last Decade

Shengyong Luo

18 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengyong Luo China 12 166 98 62 39 37 20 389
Aodi He China 12 133 0.8× 44 0.4× 46 0.7× 41 1.1× 25 0.7× 21 356
Lanlan Zhou China 11 142 0.9× 54 0.6× 20 0.3× 33 0.8× 32 0.9× 13 399
Alejandro Ferraz do Prado Brazil 12 134 0.8× 66 0.7× 95 1.5× 107 2.7× 22 0.6× 35 448
Byung‐Soon Moon South Korea 10 175 1.1× 84 0.9× 36 0.6× 31 0.8× 56 1.5× 51 449
Lingqun Zhu China 14 309 1.9× 92 0.9× 49 0.8× 18 0.5× 50 1.4× 33 550
Chin-San Liu Taiwan 12 366 2.2× 42 0.4× 73 1.2× 40 1.0× 72 1.9× 15 581
Feng-Qing Huang China 8 336 2.0× 56 0.6× 56 0.9× 68 1.7× 74 2.0× 10 545
Juthamas Khamseekaew Thailand 14 180 1.1× 59 0.6× 48 0.8× 90 2.3× 25 0.7× 30 482
Sandra Espada Spain 9 332 2.0× 32 0.3× 49 0.8× 21 0.5× 41 1.1× 10 531

Countries citing papers authored by Shengyong Luo

Since Specialization
Citations

This map shows the geographic impact of Shengyong Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengyong Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengyong Luo more than expected).

Fields of papers citing papers by Shengyong Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengyong Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengyong Luo. The network helps show where Shengyong Luo may publish in the future.

Co-authorship network of co-authors of Shengyong Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Shengyong Luo. A scholar is included among the top collaborators of Shengyong Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengyong Luo. Shengyong Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yang, Yuting, Chun Liu, Hui Cheng, et al.. (2024). Arenobufagin regulates the p62-Keap1-Nrf2 pathway to induce autophagy-dependent ferroptosis in HepG2 cells. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(7). 4895–4909. 9 indexed citations
3.
Yang, Dongmei, An Zhou, Shengyong Luo, et al.. (2024). The Effects of Crataegus pinnatifida and Wolfiporia extensa Combination on Diet-Induced Obesity and Gut Microbiota. Foods. 13(11). 1633–1633. 3 indexed citations
4.
Li, Rui, Tingting Ji, Haoran Yang, et al.. (2024). Mechanism of Astragalus mongholicus Bunge ameliorating cerebral ischemia-reperfusion injury: Based on network pharmacology analysis and experimental verification. Journal of Ethnopharmacology. 329. 118157–118157. 8 indexed citations
5.
Wang, Meng, Yueyue Li, Shanshan Li, et al.. (2023). Cinobufacini injection delays hepatocellular carcinoma progression by regulating lipid metabolism via SREBP1 signaling pathway and affecting macrophage polarization. Journal of Ethnopharmacology. 321. 117472–117472. 10 indexed citations
6.
Li, Miaomiao, Jing Gao, Liyun Wang, et al.. (2023). Basic research and clinical exploration of cold atmospheric plasma for skin wounds. Bioengineering & Translational Medicine. 8(5). e10550–e10550. 17 indexed citations
7.
Li, Rui, et al.. (2023). Loureirin B protects against cerebral ischemia/reperfusion injury through modulating M1/M2 microglial polarization via STAT6 / NF-kappaB signaling pathway. European Journal of Pharmacology. 953. 175860–175860. 31 indexed citations
8.
Gong, Peng, et al.. (2023). Downregulation of Nogo-B ameliorates cerebral ischemia/reperfusion injury in mice through regulating microglia polarization via TLR4/NF-kappaB pathway. Neurochemistry International. 167. 105553–105553. 29 indexed citations
9.
Li, Rui, Zheng Ma, Xinwei Li, et al.. (2022). Anfibatide alleviates inflammation and apoptosis via inhibiting NF-kappaB/NLRP3 axis in ischemic stroke. European Journal of Pharmacology. 926. 175032–175032. 15 indexed citations
10.
Wang, Meng, Hui Cheng, Huan Wu, et al.. (2022). Gambogenic acid antagonizes the expression and effects of long non-coding RNA NEAT1 and triggers autophagy and ferroptosis in melanoma. Biomedicine & Pharmacotherapy. 154. 113636–113636. 36 indexed citations
11.
Yi, Weizhuo, Yifu Ji, Shengyong Luo, et al.. (2022). Effects of urban particulate matter on gut microbiome and partial schizophrenia-like symptoms in mice: Evidence from shotgun metagenomic and metabolomic profiling. The Science of The Total Environment. 857(Pt 1). 159305–159305. 17 indexed citations
12.
Wu, Huan, Hui Cheng, Shengyong Luo, et al.. (2022). Use of cellular metabolomics and lipidomics to decipher the mechanism of Huachansu injection-based intervention against human hepatocellular carcinoma cells. Journal of Pharmaceutical and Biomedical Analysis. 212. 114654–114654. 17 indexed citations
13.
Ma, Zheng, Jie Zhang, Xinwei Li, et al.. (2021). Qingluoyin granules protect against adjuvant-induced arthritis in rats via downregulating the CXCL12/CXCR4-NF-κB signalling pathway. Pharmaceutical Biology. 59(1). 1439–1449. 7 indexed citations
14.
Li, Rui, et al.. (2019). Anfibatide Preserves Blood–Brain Barrier Integrity by Inhibiting TLR4/RhoA/ROCK Pathway After Cerebral Ischemia/Reperfusion Injury in Rat. Journal of Molecular Neuroscience. 70(1). 71–83. 23 indexed citations
15.
Luo, Shengyong, et al.. (2018). The Protective Effect of Total Flavones from Rhododendron simsii Planch. on Myocardial Ischemia/Reperfusion Injury and Its Underlying Mechanism. Evidence-based Complementary and Alternative Medicine. 2018(1). 6139372–6139372. 11 indexed citations
16.
Luo, Shengyong, et al.. (2017). Anfibatide protects against rat cerebral ischemia/reperfusion injury via TLR4/JNK/caspase-3 pathway. European Journal of Pharmacology. 807. 127–137. 45 indexed citations
17.
Wang, Wei, Mengyu Zhang, Qingbo Liu, et al.. (2016). The effect of ethyl acetate extract from persimmon leaves on Alzheimer's disease and its underlying mechanism. Phytomedicine. 23(7). 694–704. 26 indexed citations
18.
Luo, Shengyong, Shuo Chen, Yide Qin, & Zhiwu Chen. (2016). Urotensin-ⅡReceptor Antagonist SB-710411 Protects Rat Heart against Ischemia-Reperfusion Injury via RhoA/ROCK Pathway. PLoS ONE. 11(1). e0146094–e0146094. 26 indexed citations
19.
Li, Tingting, Xiaoyi Li, Devin M. Barry, et al.. (2015). A novel snake venom‐derived GPIb antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury. British Journal of Pharmacology. 172(15). 3904–3916. 59 indexed citations
20.
Luo, Shengyong, Liuyi Dong, Fan Li, Ming Fang, & Zhiwu Chen. (2004). Protective effect of total flavone of Camellia against cerebral ischemic injury. Traditional Chinese Drug Research and Clinical Pharmacology. 15(6). 376–379.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026